LONGITUDINAL FOLLOW UP OF SIVMAC PATHOGENESIS IN MACAQUES OF CHINESE ORIGIN

中国猕猴 SIVMAC 发病机制的纵向追踪

基本信息

  • 批准号:
    7562259
  • 负责人:
  • 金额:
    $ 7.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We have tested the dynamics of memory CD4+CCR5+ cells (target cells) in GALT in 12 SIV infected Chinese-origin rhesus macaques. Expression of T cell, naive and memory markers were measured by flow cytometry. Eight of 12 monkeys developed AIDS between 6 to 25 months after infection (progressors); 4 were long term nonprogressors (LTNPs) and remained healthy with undetectable plasma viral loads. Memory CD4+ CCR5+ cells were profoundly depleted during acute infection in all 12 monkeys. In progressors, all lacked the ability to maintain restoration of target cells. In the LTNPs, variable memory cell recovery began at day 60 PI and all had restored ¿ 15% of baseline levels by day 180 and maintained this level or increased it. In vivo CD8+ depletion in 2 LNTPs resulted in one to develop AIDS (V542) and the other (AJ07) remains healthy. Our results indicated that profound depletion of target cells in GALT was indistinguishable between progressors and LTNPs in the acute infection. Restoration of target cells during the chronic phase predicted LTNP. Sufficient CD8+ T cells are essential for controlling SIV infection in GALT and required for restoration of target cells. Moreover, host genetic protective factors such as immunogenetics was further studied by analyzing MHC class I alleles, more than 10 new MHC class I locus A and locus B alleles were identified from 9 Chinese-origin rhesus macaques with 48-190 clones per animal. However, when compared progressors with LTNPs, no association of disease progression was found with any particular MHC class I alleles. One recently published paper also indicated that control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes by David O'connor's group in the University of Wisconsin (Journal of Virology 2007406-410). Mamu-B*17 was previously recognized as an allele that associated with viral suppression and slow progression.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Binhua Julie Ling其他文献

Binhua Julie Ling的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Binhua Julie Ling', 18)}}的其他基金

CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound
CNS 骨髓细胞作为 SIV 储存库:持续感染和反弹
  • 批准号:
    9560432
  • 财政年份:
    2018
  • 资助金额:
    $ 7.16万
  • 项目类别:
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound
CNS 骨髓细胞作为 SIV 储存库:持续感染和反弹
  • 批准号:
    10390435
  • 财政年份:
    2018
  • 资助金额:
    $ 7.16万
  • 项目类别:
CNS Myeloid Cells as SIV Reservoirs: Persistent Infection and Rebound
CNS 骨髓细胞作为 SIV 储存库:持续感染和反弹
  • 批准号:
    10370645
  • 财政年份:
    2018
  • 资助金额:
    $ 7.16万
  • 项目类别:
Eradication of latent SIV from the CNS
根除中枢神经系统中潜在的 SIV
  • 批准号:
    10093149
  • 财政年份:
    2017
  • 资助金额:
    $ 7.16万
  • 项目类别:
Eradication of latent SIV from the CNS
根除中枢神经系统中潜在的 SIV
  • 批准号:
    9473820
  • 财政年份:
    2017
  • 资助金额:
    $ 7.16万
  • 项目类别:
ROLE OF NK CELLS IN SIV-INFECTED LONG-TERM NONPROGRESSING RHESUS MACAQUES
NK 细胞在 SIV 感染的长期无进展恒河猴中的作用
  • 批准号:
    8358101
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
Identification and eradication of HIV tissue reservoirs in a relevant animal mode
在相关动物模式中识别和根除 HIV 组织储存库
  • 批准号:
    8225153
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
TISSUE RESERVOIRS IN SIV-INFECTED LONG TERM NONPROGRESSORS
SIV 感染的长期无进展者的组织储库
  • 批准号:
    8358168
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
Identification and eradication of HIV tissue reservoirs in a relevant animal mode
在相关动物模式中识别和根除 HIV 组织储存库
  • 批准号:
    8418632
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:
Identification and eradication of HIV tissue reservoirs in a relevant animal mode
在相关动物模式中识别和根除 HIV 组织储存库
  • 批准号:
    8140734
  • 财政年份:
    2011
  • 资助金额:
    $ 7.16万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 7.16万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了